Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on May 14, 2025

Affimed Announces Receipt of Nasdaq Delisting Notice

Affimed Announces Receipt of Nasdaq Delisting Notice

MANNHEIM, Germany, May 14, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice from the …

Yaqrit 任命董事会及高管团队成员,旨在加强融资与监管能力并为临床试验做准备

Yaqrit 任命董事会及高管团队成员,旨在加强融资与监管能力并为临床试验做准备

美国经济战略师兼对冲基金经理Ronen Israel被任命为董事会成员,以期深化与北美地区的投资联系 Amrik Shah博士出任本公司首席生物统计官,旨在进一步提升公司在临床试验设计、统计分析以及与美国和欧洲监管机构沟通方面的专业能力 伦敦, May 14, 2025 (GLOBE NEWSWIRE) -- Yaqrit是一家处于临床研究后期的公司,致力于开发治疗晚期肝病的救命疗法。该公司今日宣布任命医疗保健创新专家兼对冲基金战略师Ronen Israel为管理董事会成员。 Ronen …

Polpharma Group Calls for Urgent Action to Protect early equitable access to medicines for European patients

Polpharma Group Calls for Urgent Action to Protect early equitable access to medicines for European patients

WARSAW, Poland, May 14, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, a leading pharmaceutical company, urges the European Union to take decisive action to conclude the pharmaceutical reform and strengthen Europe’s capacity to produce essential medicines. We …

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate the ability to specifically integrate …

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments

US economic strategist and hedge fund manager Ronen Israel appointed Board Director, deepening North American investment connectivity Amrik Shah, ScD, joins as Chief Biometrics Officer, enhancing prowess in clinical trial design, statistical analysis and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service